How osteoporosis affect people?
Osteoporosis is a chronic bone disorder characterized by porous bones, which means that the bones have lost density and become weaker and susceptible to osteoporotic fractures. It is a condition that primarily affects people over 50, with a higher prevalence of bone density loss in women. The bones of an individual with osteoporosis may appear as a “honeycomb” structure with larger spaces between the bone tissue. It is a slow-progressing and age-related condition that increases the risk of fractures. Millions of people worldwide are affected by osteoporosis, which can significantly impact the bone health and quality of life of older adults. According to the World Health Organization (WHO), approximately 54 million Americans live with osteoporosis with significant premature bone loss.
What are osteoporosis symptoms?
Osteoporosis is often referred to as a “silent disease” because many people do not experience symptoms in the early stages. As a result, it often goes undiagnosed until significant damage has occurred to the bones and their functions. The condition primarily affects weight-bearing joints, such as the hips, knees, ankles, feet, pelvis, lower back, and spine. Some common symptoms of osteoporosis include a decrease in height, stooping or bending forward, limited mobility, a history of easily broken bones or sudden bone fractures (osteoporotic fractures), shortness of breath, and lower back pain.
Procure osteoporosis samples online
The increasing incidence of osteoporosis is a significant area of research for scientists working to develop new treatments and diagnostic methods. Managing osteoporosis can be costly, particularly when it comes to osteoporotic fractures. These types of fractures often require immediate interventions such as surgery, implants, or replacement procedures to restore the affected bones' structure and function. This can lead to longer hospital stays and recovery times, contributing to healthcare costs.
Central BioHub is crucial in advancing osteoporosis research by providing a vast collection of osteoporosis biospecimens isolated from patients for research. By collaborating with top-tier human biorepositories worldwide, Central BioHub boasts an extensive inventory of high-quality human biospecimens from individuals with osteoporosis of various ages, genders, and ethnicities. The inventory includes human serum and plasma samples, as well as laboratory test results for a variety of parameters such as Rheumatoid factor antibody (RF), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) or CRP samples, anti-citrullinated protein/peptide antibodies (ACPA/anti-CCP), calcium levels, uric acid levels, and bone alkaline phosphatase levels, among others.
Central BioHub is dedicated to providing top-quality musculoskeletal disorder samples for research and development. The biosamples available at Central BioHub come with detailed descriptions and extensive annotations, including patient information, clinical evaluation profiles, and medical histories. You can visit the inventory on their website to learn more about the samples they offer and place online orders: https://centralbiohub.de/biospecimens/musculoskeletal-system-and-connective-tissue/osteoporosis
